Metabolic Syndrome in Children and Adolescents Living with HIV

María Espiau1, Diego Yeste, Antoni Noguera-Julian

  • 1From the *Pediatric Infectious Diseases and Immunodeficiencies Unit, Hospital Universitari Vall d'Hebron-Universitat Autònoma de Barcelona, Barcelona, Spain; †Pediatric Endocrinology Unit, Department of Pediatrics, Hospital Universitari Vall d'Hebron-Universitat Autònoma de Barcelona, Centre for Biomedical Research on Rare Diseases (CIBERER), Barcelona, Spain; ‡Infectious Diseases Unit, Pediatrics Department, Hospital Sant Joan de Déu-Universitat de Barcelona, Barcelona, Spain; §Pediatric Infectious Diseases and HIV Unit, Hospital Universitario 12 de Octubre, Madrid, Spain; ¶Department of Pediatric Infectious Diseases and Immunology, Hospital Universitario Virgen del Rocío, Sevilla, Spain; ‖Department of Pediatrics, Hospital Universitari Sant Joan d'Alacant, Alicante, Spain; **Infectious Diseases Unit, Department of Pediatrics, Hospital General Universitario Gregorio Marañón, Madrid, Spain; ††Infectious and Tropical Diseases Unit, Department of Pediatrics, Hospital Universitario Infantil La Paz-Hospital Carlos III, Madrid, Spain; ‡‡Infectious Diseases Unit, Department of Pediatrics, Hospital Clínico de Zaragoza, Zaragoza, Spain; §§Pediatric Infectious Diseases and HIV Unit, Complejo Hospitalario Insular Materno-Infantil de las Palmas de Gran Canaria, Las Palmas, Spain; ¶¶Infectious Diseases Unit, Department of Pediatrics, Hospital Germans Trias i Pujol, Barcelona, Spain; and ‖‖Infectious Diseases Unit, Department of Pediatrics, Hospital Infantil Universitario Miguel Servet, Zaragoza, Spain.

Insights

Metabolic syndrome (MetS) affects pediatric HIV patients, with prevalence varying by diagnostic criteria. Active assessment is crucial, especially for children with lipohypertrophy.

Area of Science:

  • Pediatric Endocrinology
  • Infectious Diseases
  • Cardiovascular Health

Background:

  • Metabolic syndrome (MetS) is a significant risk factor for cardiovascular disease.
  • Metabolic disorders are increasingly prevalent in children with HIV.
  • This study investigates MetS in HIV-infected children in Spain.

Purpose of the Study:

  • To determine the prevalence and characteristics of MetS in HIV-infected children and adolescents.
  • To compare MetS prevalence using different diagnostic criteria.

Main Methods:

  • A cross-sectional multicenter study of 152 pediatric patients from the Spanish AIDS Research Network (CoRISpe).
  • MetS diagnosed using International Diabetes Federation (IDF) and modified National Cholesterol Education Program Adult Treatment Panel III (NCEP-ATP III) criteria.
  • Data included anthropometry, blood pressure, lipids, glucose, insulin, and lipodystrophy assessment.

Main Results:

  • Low high-density lipoprotein-cholesterol was the most common abnormality (21.05%).
  • MetS prevalence was 1.97% (IDF criteria) and 5.92% (modified NCEP-ATP III criteria).
  • MetS was associated with lipohypertrophy, Tanner stage, and elevated BMI Z-scores.

Conclusions:

  • MetS prevalence in pediatric HIV-infected patients varies by diagnostic criteria (1.97%-5.92%).
  • Lipohypertrophy is a key indicator for MetS assessment in this population.
  • Regular screening for MetS is recommended for HIV-infected children.
Abstract

Related Concept Videos

Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
2.8K
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
327
Sexually Transmitted Infections01:26

Sexually Transmitted Infections

Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
1.6K
Overview of Carbohydrate Metabolism01:19

Overview of Carbohydrate Metabolism

Carbohydrate metabolism is a fundamental biochemical process that ensures a constant supply of energy to living cells. The most important carbohydrate is glucose, which can be broken down via glycolysis to enter into the Krebs cycle and eventually lead to the production of ATP through oxidative phosphorylation.
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
4.3K
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
2.7K
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
5.9K